Company Filing History:
Years Active: 2013-2016
Title: Innovations of Jonathan James Hollick
Introduction
Jonathan James Hollick is a notable inventor based in Perth, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. With a total of 3 patents to his name, Hollick's work is recognized for its potential impact on the treatment of proliferative disorders.
Latest Patents
Hollick's latest patents include innovative pyrimidine derivatives that serve as protein kinase inhibitors. The first patent describes these derivatives as capable of inhibiting one or more protein kinases. It also discusses pharmaceutical compositions that incorporate these compounds and their application in treating proliferative disorders. The second patent further elaborates on a specific compound formula, detailing its structural components and potential uses in pharmaceutical formulations.
Career Highlights
Hollick is currently associated with Cyclacel Limited, a company focused on developing innovative cancer therapies. His work at Cyclacel has allowed him to explore the therapeutic potential of his inventions in a collaborative environment.
Collaborations
Some of his coworkers include Stuart Donald Jones and Claire June Flynn, who contribute to the innovative research and development efforts at Cyclacel Limited.
Conclusion
Jonathan James Hollick's contributions to the field of pharmaceuticals through his patents on pyrimidine derivatives highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of proliferative disorders.